모르핀 약물 시장 보고서(2026년)

Morphine drugs are a category of medications that include morphine, a powerful opioid pain-relieving substance obtained from the opium poppy plant. These drugs are used to manage moderate to severe pain, often following surgery or injury, or in the treatment of conditions such as cancer.

The primary dosage forms of morphine medications include injectable, oral, and other formulations. Injectables are drugs or substances designed to be delivered directly into the body through injection, allowing rapid action by avoiding the digestive system. The different distribution channels comprise hospital pharmacies, retail pharmacies, and online pharmacies, serving multiple applications such as pain management, palliative care, diarrhea control, anesthesia, cold and cough relief, and others, and are utilized by various end users including hospitals and clinics, ambulatory surgical centers, and others.

Tariffs have affected the morphine drugs market by increasing costs associated with the import of raw opium derivatives, active pharmaceutical ingredients, and specialized manufacturing inputs. These impacts are most pronounced in regions dependent on international sourcing, particularly North America and Europe. Higher input costs have pressured pricing and supply planning for generic manufacturers. At the same time, tariffs have encouraged domestic production, local sourcing, and tighter supply chain controls to ensure drug availability.

The morphine drugs market research report is one of a series of new reports from The Business Research Company that provides morphine drugs market statistics, including morphine drugs industry global market size, regional shares, competitors with a morphine drugs market share, detailed morphine drugs market segments, market trends and opportunities, and any further data you may need to thrive in the morphine drugs industry. This morphine drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The morphine drugs market size has grown strongly in recent years. It will grow from $23.09 billion in 2025 to $24.51 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to longstanding clinical reliance on morphine for severe pain relief, widespread use in post-surgical and trauma care, established role in cancer pain management, inclusion in essential medicines lists, availability of multiple generic morphine formulations.

The morphine drugs market size is expected to see strong growth in the next few years. It will grow to $30.17 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising cancer prevalence requiring strong analgesics, growing demand for palliative care services, expansion of hospital infrastructure in emerging markets, continued need for anesthesia and perioperative pain control, balanced opioid use under stricter regulatory frameworks. Major trends in the forecast period include sustained demand for opioid analgesics in severe pain management, continued use of morphine in palliative and end-of-life care, preference for injectable morphine in hospital settings, availability of multiple dosage forms for clinical flexibility, growing emphasis on controlled and regulated opioid prescribing.

The rising prevalence of chronic pain conditions is anticipated to drive the growth of the morphine drugs market in the coming years. Chronic pain is a multifaceted condition marked by ongoing discomfort that persists over a long duration and acts as an indicator of injury or disease. It has become a significant global health issue due to several interconnected factors, including aging populations, increasing obesity levels, inactive lifestyles, stress and mental health challenges, and environmental influences. Morphine plays a vital role in managing chronic pain because it is highly effective in pain relief and can be tailored to address the individual needs of patients. It improves quality of life and allows people living with chronic pain to function more effectively without constant severe discomfort. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based national public health agency, an estimated 24.3% of adults experienced chronic pain in 2023, with 8.5% amounting to roughly one-third of those affected reporting high-impact chronic pain, and women showing higher prevalence than men. Hence, the growing prevalence of chronic pain conditions is contributing to the expansion of the morphine drug market.

Major companies active in the morphine drug sector are concentrating on the development of advanced drug delivery solutions, such as prefilled syringe formats, to improve operational efficiency, increase safety, and minimize medication errors and preparation time. Prefilled syringes are sterile, single-use delivery systems that come preloaded with a predetermined dose of medication, removing the need to manually draw the drug from a vial prior to administration. For example, in April 2024, Hikma Pharmaceuticals PLC, a UK-based multinational pharmaceutical firm, introduced Morphine Sulfate Injection USP in a prefilled syringe in the U.S. market. This product offers a ready-to-administer, sterile form of the opioid analgesic, improving convenience for healthcare professionals in acute care environments. The prefilled syringe is intended to lower the risk of dosing inaccuracies and enhance workflow efficiency by reducing preparation steps.

In January 2024, CDMO Bora Pharmaceuticals Inc., a Taiwan-based pharmaceutical firm, acquired Upsher-Smith Laboratories Inc. for $210 million. This acquisition is intended to reinforce Bora's presence in the generics segment by broadening its product portfolio, enhancing manufacturing capabilities, encouraging innovation, and enabling expansion into new geographic regions. Upsher-Smith Laboratories Inc. is a US-based pharmaceutical company engaged in the production of morphine drugs.

Major companies operating in the morphine drugs market are Pfizer Inc., Sanofi S.A., Rusan Pharma Ltd., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sandoz AG, Viatris Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Johnson Matthey Fine Chemicals, Fresenius Kabi USA LLC, Delpharm SaS, Alvogen Inc., Mallinckrodt Pharmaceuticals, Lannett Company, Mayne Pharma Group Limited, Noramco Inc., Tasmanian Alkaloids, Napp Pharmaceuticals Limited, Alcaliber SA

North America was the largest region in the morphine drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the morphine drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the morphine drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The morphine drugs market consists of sales of morphine sulfate, Roxanol oral solution, Kadian capsules, morphine injections, and Avinza capsules. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Morphine Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses morphine drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for morphine drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The morphine drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Dosage form: Injectable; Oral; Other Dosage Forms
• 2) By Distribution channels: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• 3) By Applications: Pain Management; Palliative Care; Diarrhea Suppressant; Anesthesia; Other Applications
• 4) By End Users: Hospitals And Clinics; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Injectable: Morphine Sulfate Injection; Morphine Hydrochloride Injection; Morphine Extended Release Injection
• 2) By Oral: Oral Tablets (Immediate-Release, Extended-Release); Oral Solution Or syrup; Oral Capsules (Extended-Release Capsules)
• 3) By Other Dosage Forms: Rectal Suppositories; Sublingual Tablets Or Films
• Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Rusan Pharma Ltd.; Johnson & Johnson; Teva Pharmaceutical Industries Ltd.; Daiichi Sankyo Company Limited; Sandoz AG; Viatris Inc.; Dr. Reddy's Laboratories Ltd.; Apotex Inc.; Hikma Pharmaceuticals PLC; Endo Pharmaceuticals Inc.; Sun Pharmaceutical Industries Ltd.; Johnson Matthey Fine Chemicals; Fresenius Kabi USA LLC; Delpharm SaS; Alvogen Inc.; Mallinckrodt Pharmaceuticals; Lannett Company; Mayne Pharma Group Limited; Noramco Inc.; Tasmanian Alkaloids; Napp Pharmaceuticals Limited; Alcaliber SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Morphine Drugs Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Morphine Drugs Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Morphine Drugs Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Morphine Drugs Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Sustained Demand For Opioid Analgesics In Severe Pain Management
  • 4.2.2 Continued Use Of Morphine In Palliative And End-Of-Life Care
  • 4.2.3 Preference For Injectable Morphine In Hospital Settings
  • 4.2.4 Availability Of Multiple Dosage Forms For Clinical Flexibility
  • 4.2.5 Growing Emphasis On Controlled And Regulated Opioid Prescribing

5. Morphine Drugs Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Ambulatory Surgical Centers
• 5.3 Palliative Care Centers
• 5.4 Cancer Treatment Centers
• 5.5 Pain Management Clinics

6. Morphine Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Morphine Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Morphine Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Morphine Drugs Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Morphine Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Morphine Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Morphine Drugs Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Morphine Drugs Market Segmentation

• 9.1. Global Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Injectable, Oral, Other Dosage Forms
• 9.2. Global Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
• 9.3. Global Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pain Management, Palliative Care, Diarrhea Suppressant, Anesthesia, Other Applications
• 9.4. Global Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users
• 9.5. Global Morphine Drugs Market, Sub-Segmentation Of Injectable, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Morphine Sulfate Injection, Morphine Hydrochloride Injection, Morphine Extended Release Injection
• 9.6. Global Morphine Drugs Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Tablets (Immediate-Release, Extended-Release), Oral Solution Or syrup, Oral Capsules (Extended-Release Capsules)
• 9.7. Global Morphine Drugs Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rectal Suppositories, Sublingual Tablets Or Films

10. Morphine Drugs Market Regional And Country Analysis

• 10.1. Global Morphine Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Morphine Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Morphine Drugs Market

• 11.1. Asia-Pacific Morphine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Morphine Drugs Market

• 12.1. China Morphine Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Morphine Drugs Market

• 13.1. India Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Morphine Drugs Market

• 14.1. Japan Morphine Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Morphine Drugs Market

• 15.1. Australia Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Morphine Drugs Market

• 16.1. Indonesia Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Morphine Drugs Market

• 17.1. South Korea Morphine Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Morphine Drugs Market

• 18.1. Taiwan Morphine Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Morphine Drugs Market

• 19.1. South East Asia Morphine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Morphine Drugs Market

• 20.1. Western Europe Morphine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Morphine Drugs Market

• 21.1. UK Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Morphine Drugs Market

• 22.1. Germany Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Morphine Drugs Market

• 23.1. France Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Morphine Drugs Market

• 24.1. Italy Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Morphine Drugs Market

• 25.1. Spain Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Morphine Drugs Market

• 26.1. Eastern Europe Morphine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Morphine Drugs Market

• 27.1. Russia Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Morphine Drugs Market

• 28.1. North America Morphine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Morphine Drugs Market

• 29.1. USA Morphine Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Morphine Drugs Market

• 30.1. Canada Morphine Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Morphine Drugs Market

• 31.1. South America Morphine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Morphine Drugs Market

• 32.1. Brazil Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Morphine Drugs Market

• 33.1. Middle East Morphine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Morphine Drugs Market

• 34.1. Africa Morphine Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Morphine Drugs Market, Segmentation By Dosage form, Segmentation By Distribution channels, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Morphine Drugs Market Regulatory and Investment Landscape

36. Morphine Drugs Market Competitive Landscape And Company Profiles

• 36.1. Morphine Drugs Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Morphine Drugs Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Morphine Drugs Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Rusan Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Morphine Drugs Market Other Major And Innovative Companies

• Daiichi Sankyo Company Limited, Sandoz AG, Viatris Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Johnson Matthey Fine Chemicals, Fresenius Kabi USA LLC, Delpharm SaS, Alvogen Inc., Mallinckrodt Pharmaceuticals, Lannett Company, Mayne Pharma Group Limited

38. Global Morphine Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Morphine Drugs Market

40. Morphine Drugs Market High Potential Countries, Segments and Strategies

• 40.1 Morphine Drugs Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Morphine Drugs Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Morphine Drugs Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer